Mutations in presenilin 1 (PS1) lead to dominant inheritance of early onset familial Alzheimer disease (FAD). These mutations are known to alter the ␥-secretase cleavage of the amyloid precursor protein, resulting in increased ratio of A42/A40 and accelerated amyloid plaque pathology in transgenic mouse models. To investigate the factors that drive the A42/A40 ratio and amyloid pathogenesis and to investigate the possible interactions between wildtype and FAD mutant PS1, which are co-expressed in transgenic animals, we expressed the PS1 M146V knock-in allele either on wild-type PS1 (PS1 M146V/؉ ) or PS1 null (PS1 M146V/؊ ) background and crossed these alleles with the Tg2576 APP transgenic mice. Introduction of the PS1 M146V mutation on Tg2576 background resulted in earlier onset of plaque pathology. Surprisingly, removing the wild-type PS1 in the presence of the PS1 M146V mutation (PS1 M146V/؊ ) greatly exacerbated the amyloid burden; and this was attributed to a reduction of ␥-secretase activity rather than an increase in A42. Our findings establish a protective role of the wild-type PS1 against the FAD mutation-induced amyloid pathology through a partial loss-of-function mechanism.The pathological hallmark defining Alzheimer disease (AD) 3 is the deposition of -amyloid plaques of which the principal components are 40 -42-amino acid peptides referred to as the -amyloid peptides (A), which are derived by proteolytic cleavages of the amyloid precursor protein (APP). APP is processed by at least three proteinases known as ␣-, -, and ␥-secretases. Both ␣-and -secretases (BACE1) process APP in the extracellular domain with ␣-secretase cleavage occurring inside the A domain and BACE1 at the amino terminus of A. These proteolytic events generate APP carboxyl-terminal fragments (CTF), which serve as substrates for subsequent ␥-secretase processing, producing either p3 (product of ␣-and ␥-secretases) or A peptides (product of BACE1 and ␥-secretase) (reviewed in Ref. 1). The ␥-secretase activity is executed by a high molecular weight complex of which presenilin 1 (PS1) is an essential component (reviewed in Ref. 2). As such, inhibition of PS1 leads to the accumulation of APP-CTF (3-5). The ␥-secretase exhibits relaxed sequence specificity (6). In addition to APP and in an extracellular cleavage-dependent manner, PS1 has been implicated in the processing of a growing list of type I membrane proteins including Notch (7), N-and E-cadherins (8, 9), and the tyrosinase family of proteins (Ref. 10 and reviewed in Ref. 11).Besides the ␥-sites that generate A40 and A42, PS1-dependent proteolysis also occurs at other positions including the -site (A46) and ⑀-site (A49) (12)(13)(14). Recent evidence supports a sequential cleavage model in which ⑀-cleavage at the cytosol-membrane junction serves as the initial cutting site followed by -and ␥-processing within the membrane (14). Therefore, although A40 and A42 are measurements of specific products of ␥-secretase cleavage of APP, levels of the CTF of APP as well ...